0J5Q Stock Overview
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Hologic, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$77.11 |
52 Week High | US$86.55 |
52 Week Low | US$64.69 |
Beta | 1.0 |
1 Month Change | 2.32% |
3 Month Change | 8.69% |
1 Year Change | -3.55% |
3 Year Change | 2.51% |
5 Year Change | 59.81% |
Change since IPO | 77.75% |
Recent News & Updates
Recent updates
Shareholder Returns
0J5Q | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 2.2% | 1.4% | 2.3% |
1Y | -3.5% | 3.6% | 2.7% |
Return vs Industry: 0J5Q underperformed the UK Medical Equipment industry which returned 2.3% over the past year.
Return vs Market: 0J5Q underperformed the UK Market which returned 3.7% over the past year.
Price Volatility
0J5Q volatility | |
---|---|
0J5Q Average Weekly Movement | 2.5% |
Medical Equipment Industry Average Movement | 7.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: 0J5Q has not had significant price volatility in the past 3 months.
Volatility Over Time: 0J5Q's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 6,990 | Steve MacMillan | https://www.hologic.com |
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth.
Hologic, Inc. Fundamentals Summary
0J5Q fundamental statistics | |
---|---|
Market cap | US$18.16b |
Earnings (TTM) | US$515.10m |
Revenue (TTM) | US$3.97b |
35.2x
P/E Ratio4.6x
P/S RatioIs 0J5Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0J5Q income statement (TTM) | |
---|---|
Revenue | US$3.97b |
Cost of Revenue | US$1.55b |
Gross Profit | US$2.42b |
Other Expenses | US$1.91b |
Earnings | US$515.10m |
Last Reported Earnings
Dec 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 2.19 |
Gross Margin | 60.99% |
Net Profit Margin | 12.98% |
Debt/Equity Ratio | 55.0% |
How did 0J5Q perform over the long term?
See historical performance and comparison